SOPHIA ZHANG: Open Payments
NPI 1043898109 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 34 payments from 14 companies in 2025. Trend: 2023 $1,148 · 2024 $1,354 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $156 |
| GENZYME CORPORATION | 1 | $129 |
| Axsome Therapeutics, Inc. | 4 | $125 |
| E.R. Squibb & Sons, L.L.C. | 4 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Almatica Pharma LLC | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Noven Therapeutics, LLC | 2 | $37 |
Products named: KEVZARA, Auvelity, COBENFY, UZEDY, AUSTEDO XR, CAPLYTA, SPRAVATO, LOREEV XR.
Industry payments across FL — which companies pay providers there.
